ArticleRadiation oncology (London, England)2025
A contrast‑enhanced CT histogram‑driven nomogram for predicting post‑radiotherapy liver regeneration in hepatocellular carcinoma.
Article in Radiation oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPostoperative radiotherapy (RT) is increasingly used in hepatocellular carcinoma (HCC) patients with high-risk pathological features to reduce recurrence. However, RT may compromise liver regeneration (LR), particularly in patients with underlying hepatic dysfunction. Accurate evaluation of LR potential is therefore critical for individualized treatment planning.
methodsIn this retrospective, multicenter study, 315 HCC patients were enrolled—139 in the training cohort and 85 and 91 in two external validation cohorts. All patients underwent postoperative intensity-modulated radiotherapy (IMRT), and pre-RT portal-venous phase contrast-enhanced computed tomography (CE-CT) scans were analyzed to extract whole-liver histogram features. Patients with a ≥ 10% increase in remnant liver volume within 1 year were classified as effective liver regeneration (ELR), and the remainder as impaired liver regeneration (ILR). Independent predictors of ELR were identified using logistic regression, and a nomogram was developed and evaluated with ROC, calibration, and decision-curve analyses.
resultsAmong the 315 patients, 187 (59.4%) achieved ELR and 128 (40.6%) showed ILR. Multivariate analysis identified kurtosis, mean liver dose (Liver-Dmean), standardized remnant liver volume (SRLV), and fibrosis stage as independent predictors of ELR. The nomogram demonstrated robust performance with AUCs of 0.866 (95% CI: 0.804–0.928) in the training cohort and 0.794 (95% CI: 0.698–0.889) and 0.733 (95% CI: 0.617–0.848) in the validation cohorts.
conclusionWe established and externally validated a CE-CT histogram-based nomogram that accurately predicts LR following adjuvant IMRT in high-risk HCC patients. This model offers a clinically applicable tool to optimize postoperative management by balancing oncologic control with preservation of hepatic function.
trial registrationThis is a study that follows the Declaration of Helsinki and good clinical practice guidelines, and was approved by the Ethics Committee of Lanzhou University Second Hospital, the second affiliated hospital of shandong first medical university and the Affiliated Hospital of Qingdao University(approval no. 2025 A-539). As a retrospective analysis without any intervention in patient treatment, the Ethics Committees waived the requirement for individual informed consent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.